Latest

Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆

Updated 06 Sep 2026 · ClinicalTrials.gov

Clinical Trials in Sutton

← All UK trials

The most recently updated industry-sponsored clinical trials recruiting across the United Kingdom — searchable by condition, sponsor, phase and city. Refreshed daily from the ClinicalTrials.gov registry.

10

Recruiting now

13

Studies tracked

Sutton

Selected city

Active Phase 3

A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma.

Follicular Lymphoma, Marginal Zone Lymphoma
Incyte Corporation · started 2021-04-15

Birmingham · Bristol · Leicester · London · Manchester

NCT04680052 on ClinicalTrials.gov ↗

Recruiting Phase 1/Phase 2

A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer

Advanced Prostate Cancer, Metastatic Prostate Cancer
Genentech, Inc. · started 2026-04-29

Sutton

NCT07567846 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)

Small-cell Lung Cancer
Zai Lab (Shanghai) Co., Ltd. · started 2025-11-30

Cambridge · London · Chelsea · Sutton · Stoke-on-Trent

NCT07218146 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
Merck Sharp & Dohme LLC · started 2025-04-09

Cambridge · Edinburgh · Preston · London · Sutton

NCT06824467 on ClinicalTrials.gov ↗

Recruiting Phase 2

A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer

Metastatic Castration-Resistant Prostate Cancer
Hoffmann-La Roche · started 2026-03-11

Sutton · Cardiff

NCT07287150 on ClinicalTrials.gov ↗

Active Phase 1

Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in Participants With Solid Tumors

Solid Tumors
ModernaTX, Inc. · started 2017-08-14

Dundee · Sutton · London

NCT03313778 on ClinicalTrials.gov ↗

Recruiting Phase 1/Phase 2

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma, Burkitt Lymphoma, Neuroblastoma
Merck Sharp & Dohme LLC · started 2024-08-16

Birmingham · Newcastle upon Tyne · London · Sutton · Cardiff

NCT06395103 on ClinicalTrials.gov ↗

Recruiting Phase 3

Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

Non-small Cell Lung Cancer
Boehringer Ingelheim · started 2026-01-16

Cardiff · Edinburgh · London · Manchester · Sutton

NCT07195695 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

Prostate Cancer, Prostatic Neoplasms
Merck Sharp & Dohme LLC · started 2025-05-13

Cambridge · London · Exeter · Birmingham · Northwood

NCT06925737 on ClinicalTrials.gov ↗

Recruiting Phase 3

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

Metastatic Colorectal Cancer
Amgen · started 2024-07-17

Birmingham · Glasgow · London · Maidstone · Northwood

NCT06252649 on ClinicalTrials.gov ↗

Recruiting Phase 1/Phase 2

A Modular Phase 1/2 Study With CT7439 in Participants With Solid Malignancies

Solid Malignancies
Carrick Therapeutics Limited · started 2024-08-16

Manchester · Oxford · Sutton

NCT06600789 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

Metastatic Castration-resistant Prostate Cancer
BioNTech SE · started 2026-04-22

Cambridge · London · Sutton

NCT07365995 on ClinicalTrials.gov ↗

Active Phase 1

A Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer Compared With Pembrolizumab Alone

Head and Neck Squamous Cell Carcinoma
Boehringer Ingelheim · started 2025-05-14

London · Sutton

NCT06806852 on ClinicalTrials.gov ↗

No trials match your search.

Browse by city

London · 112 Manchester · 38 Cambridge · 28 Glasgow · 27 Birmingham · 27 Oxford · 23 Leicester · 20 Bristol · 20 Leeds · 16 Cardiff · 16 Liverpool · 15 Edinburgh · 13 Sheffield · 13 Sutton · 13 Newcastle upon Tyne · 12 Exeter · 12

Browse by condition

Obesity · 5 Breast Cancer · 5 Solid Tumors · 4 Overweight · 4 Non-small Cell Lung Cancer · 3 Ovarian Cancer · 3 Prostate Cancer · 3 Cardiovascular Diseases · 3 Bladder Cancer · 2 Diabetes Mellitus, Type 1 · 2 Chronic Migraine · 2 Systemic Lupus Erythematosus · 2 Non-small Cell Lung Cancer (NSCLC) · 2 Hypertension · 2 Systemic Lupus Erythematosus (SLE) · 2 Ulcerative Colitis · 2

Cite this page

Priya Life Science (2026). Clinical Trials in the UK Tracker. Available at: https://priyalifescience.com/clinical-trials-uk/city/sutton (Accessed: 6 September 2026).

Embed this data ↗

Source: ClinicalTrials.gov, U.S. National Library of Medicine — industry-sponsored studies in a recruiting status with at least one UK site, most recently updated first, refreshed daily. This is a curated slice of the registry, not every UK trial; UK studies may also be registered on ISRCTN. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. Compare pay for the teams running these studies in our UK Pharma Salary Guide, or see our Ireland, EU and USA trackers.